Skip to main content

Advertisement

Log in

Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Axillary lymph nodes status is the most important prognosis factor in early breast cancer. This status is known by a selective sentinel lymph node biopsy (SLNB) and/or lymphadenectomy. Immunohistochemical studies of breast cancer tumour tissue have reported a relation between the increased expression of vascular endothelial growth factor-C (VEGF-C) and the risk of lymph node metastasis. We researched whether serum levels of VEGF-C could be a predictor factor of sentinel lymph node status in these patients. A prospective analysis was performed on serum from 174 patients with early breast cancer who underwent SLNB. The level of VEGF-C was determined by enzyme-linked immunosorbent assay. Clinical-pathologic variables were collected. Univariate analysis and multivariate logistic regression were conducted, taking SLNB positivity as the segmentation variable. The predictive value of VEGF-C was assessed using ROC curves. Of the sample group of 167 patients, 64 (38.3 %) had affected lymph node. Eighteen patients (28.1 %) presented micrometastasis; there were isolated tumour cells in 11 cases (17.2 %) and macrometastasis in 35 (54.6 %). The median value of VEGF-C was 6561.5 pg/ml. These values did not correlate with any clinical variables, and there was no association between the level of VEGF-C and SLNB status (p = 0.626). In the multivariate analysis, tumour size (p = 0.009) and the presence of vascular invasion (p < 0.001) were independently associated with sentinel lymph node affected. Serum levels of VEGF-C do not appear to predict sentinel lymph node status in patients with early breast cancer who undergo SLNB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Burstein HJ, Harris JR, Morrow M. Malignant tumors of the breast. In: De Vita VT, Lawrence TH, Rosenberg SA, editors. Cancer Principles & Practice of Oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1606–54.

    Google Scholar 

  2. Veronessi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Eng J Med. 2003;349:546–53.

    Article  Google Scholar 

  3. Purushotham AD, Upponi S, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312–21.

    Article  PubMed  Google Scholar 

  4. Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65:34–9.

    Article  CAS  PubMed  Google Scholar 

  5. Silverstein MJ, Skinner KA, Lomis TL. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–72.

    Article  CAS  PubMed  Google Scholar 

  6. Montgomery LL, Thorne AC, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385–8.

    PubMed  Google Scholar 

  7. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75.

    Article  PubMed  Google Scholar 

  8. Giuliano A, Hunt K, Ballman K, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305:569–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dauphine CE, Haukoos JS, Vargas MP, Isaac NM, Khalkhali I, Vargas HI. Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2007;14:1014–9.

    Article  PubMed  Google Scholar 

  10. Sunder SS, Ganesan TS. Role of lymphangiogenesis in cancer. J Clin Oncol. 2007;25:4298–307.

    Article  Google Scholar 

  11. Pepper MS, Tille JC, Nisato R, et al. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003;314:167–77.

    Article  CAS  PubMed  Google Scholar 

  12. Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 2003;63:713–22.

    CAS  PubMed  Google Scholar 

  13. Lin J, Lalani AS, Harding TC, et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Sci. 2004;65:6901–9.

    Google Scholar 

  14. Mohammed RA, Green A, El-Shikh S, et al. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer. 2007;96:1092–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang XH, Huang DP, Guo GL, et al. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer. 2008;8:4. doi:10.1186/1471-2407-8-4.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th ed. 2010.

  17. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368–73.

    Article  CAS  PubMed  Google Scholar 

  18. Viale G, Bosari S, Mazzarol GM, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999;85:2433–8.

    Article  CAS  PubMed  Google Scholar 

  19. Gisterek I, Matkowski R, Lacko A, et al. Serum vascular endothelial growth factors a, C and d in human breast tumors. Pathol Oncol Res. 2010;16:337–44.

    Article  CAS  PubMed  Google Scholar 

  20. Rueda A, Rifa J, Quero C, et al. High serum levels of vascular endothelial growth factor C have a positive impact on outcome of patients with advanced diffuse large B cells lymphoma. Leuk Lymphoma. 2014;55(6):1413–6. doi:10.3109/10428194.2013.836601.

    Article  PubMed  Google Scholar 

  21. Schoppmann S et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004;240(2):306–12.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu. 1983;18(Pt 2):215–32.

    PubMed  Google Scholar 

  23. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.

    Article  PubMed  Google Scholar 

  24. McCready DR, Yong WS, et al. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst. 2004;96:873–5.

    Article  PubMed  Google Scholar 

  25. Viale G, Zurrida S, Maiorano E, et al. Predicting the status of auxillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103:492–500.

    Article  PubMed  Google Scholar 

  26. Shibata MA, Morimoto J, Shibata J, Otsuki Y. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther. 2008;15:776–86.

    Article  CAS  PubMed  Google Scholar 

  27. Xiao-wen HE, Xiao YU, Ting L, Shi-yi YU, Dao-jin C. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. Chin Med J. 2008;121:439–44.

    Google Scholar 

  28. Al-Mowallad A, Kirwan C, Byrne G, et al. Vascular endothelial growth factor-C in patients with breast cancer. In Vivo. 2007;21:549–51.

    CAS  PubMed  Google Scholar 

  29. Tamura M, Ohta Y. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma. A possible diagnostic tool for lymph node metastasis. Cancer. 2003;98:1217–22.

    Article  CAS  PubMed  Google Scholar 

  30. Tsirlis TD, Papastratis G, Masselou K, et al. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol. 2008;14:2691–701.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wang TB, Deng MH, Qiu WS, Dong WG. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol. 2007;13:1794–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Tamura M, Oda M, Tsunezuka Y, et al. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest. 2004;126:342–6.

    Article  CAS  PubMed  Google Scholar 

  33. Morgillo F, De Vita F, Antoniol G, et al. Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol. 2013;20:e283–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res. 2000;6:3147–52.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the patients and family for their help to do this work.

Ethical standards

This study was approved by the hospital ethics committee and was conducted in accordance with the principles of the Declaration of Helsinki (Seoul, 2008). All patients gave their written informed consent to participate in the study. Project data were collected anonymously, following Spanish data protection legislation (Act 15/1999 of 15 December).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisabeth Pérez-Ruiz.

Additional information

Drs Rueda, Zarcos and Pérez-Ruiz and Rivas-Ruiz and Redondo belong to REDISSEC.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pérez, D., Rohde, A., Callejón, G. et al. Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer. Tumor Biol. 36, 9285–9293 (2015). https://doi.org/10.1007/s13277-015-3663-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3663-0

Keywords

Navigation